E-mail

E-mail a Wiley Online Library Link

Heiner Wedemeyer, Donald Jensen, Robert Herring Jr., Peter Ferenci, Mang-Ming Ma, Stefan Zeuzem, Maribel Rodriguez-Torres, Natalie Bzowej, Paul Pockros, John Vierling, David Ipe, Marie Lou Munson, Ya-Chi Chen, Isabel Najera, James Thommes and on behalf of the PROPEL Investigators PROPEL: A randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients Hepatology 58

Version of Record online: 26 JUN 2013 | DOI: 10.1002/hep.26274

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH